Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Macular Degeneration and KDR[original query] |
---|
Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor. Ophthalmology 2010 Sep 117 (9): 1769-74. Galan Alessandro, Ferlin Alberto, Caretti Luigi, Buson Genny, Sato Giovanni, Frigo Anna Chiara, Foresta Car |
Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD. Investigative ophthalmology & visual science 2011 Jun 52 (7): 4694-702. Kloeckener-Gruissem Barbara, Barthelmes Daniel, Labs Stephan, Schindler Christian, Kurz-Levin Malaika, Michels Stephan, Fleischhauer Johannes, Berger Wolfgang, Sutter Florian, Menghini More |
Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration. Ophthalmology 2012 Jul . Smailhodzic D, Muether PS, Chen J, Kwestro A, Zhang AY, Omar A, Van de Ven JP, Keunen JE, Kirchhof B, Hoyng CB, Klevering BJ, Koenekoop RK, Fauser S, den Hollander AI |
Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration. Molecular vision 2012 18 . Wang VM, Rozen RB, Meyerle CB, Kurup SK, Ardeljan D, Agron E, Tai K, Pomykala M, Chew EY, Chan CC, Tuo J |
Pharmacogenetic association with early response to intravitreal ranibizumab for age-related macular degeneration in a Korean population. Molecular vision 2013 19 702-9. Chang Woohyok, Noh Dong Hyoun, Sagong Min, Kim In Ta |
Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration. Ophthalmology 2014 Apr 121 (4): 905-10. Hermann Manuel M, van Asten Freekje, Muether Philipp S, Smailhodzic Dzenita, Lichtner Peter, Hoyng Carel B, Kirchhof Bernd, Grefkes Christian, den Hollander Anneke I, Fauser Sasc |
FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression. Investigative ophthalmology & visual science 2014 Jun 55 (6): 3543-54. Owen Leah A, Morrison Margaux A, Ahn Jeeyun, Woo Se Joon, Sato Hajime, Robinson Rosann, Morgan Denise J, Zacharaki Fani, Simeonova Marina, Uehara Hironori, Chakravarthy Usha, Hogg Ruth E, Ambati Balamurali K, Kotoula Maria, Baehr Wolfgang, Haider Neena B, Silvestri Giuliana, Miller Joan W, Tsironi Evangelia E, Farrer Lindsay A, Kim Ivana K, Park Kyu Hyung, DeAngelis Margaret |
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration. Pharmacogenetics and genomics 2015 Sep . Lorés-Motta Laura, van Asten Freekje, Muether Philipp S, Smailhodzic Dzenita, Groenewoud Joannes M, Omar Amer, Chen John, Koenekoop Robert K, Fauser Sascha, Hoyng Carel B, den Hollander Anneke I, de Jong Eiko |
Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration. BMJ open ophthalmology 2019 4 (1): e000273. Balikova Irina, Postelmans Laurence, Pasteels Brigitte, Coquelet Pascale, Catherine Janet, Efendic Azra, Hosoda Yoshikatsu, Miyake Masahiro, Yamashiro Kenji, , Thienpont Bernard, Lambrechts Dieth |
Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients. Pharmaceutics 2022 7 14 (8): . Blánquez-Martínez David, Díaz-Villamarín Xando, García-Rodríguez Sonia, Antúnez-Rodríguez Alba, Pozo-Agundo Ana, Martínez-González Luis Javier, Muñoz-Ávila José Ignacio, Dávila-Fajardo Cristina Luc |
CFH (rs1061170, rs1410996), KDR (rs2071559, rs1870377) and KDR and CFH Serum Levels in AMD Development and Treatment Efficacy. Biomedicines 2024 5 12 (5): . Dzastina Cebatoriene, Alvita Vilkeviciute, Greta Gedvilaite, Akvile Bruzaite, Loresa Kriauciuniene, Dalia Zaliuniene, Rasa Liutkevicie |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 11, 2024
- Content source: